ALBRECHT BRIAN K has a total of 16 patent applications. Its first patent ever was published in 2005. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are INST OF MATARIA MEDICA CHINESE, INVASC THERAPEUTICS INC and EXSCIENTIA LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | WIPO (World Intellectual Property Organization) | 4 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Albrecht Brian K | 16 |
#2 | Harmange Jean-Christophe | 14 |
#3 | Bellon Steven | 7 |
#4 | Boezio Alessandro | 6 |
#5 | Choquette Deborah | 6 |
#6 | Taylor Alexander M | 5 |
#7 | Lohman Julia | 5 |
#8 | Xi Ning | 5 |
#9 | Bode Christiane M | 5 |
#10 | Bauer David | 5 |
Publication | Filing date | Title |
---|---|---|
US2014005169A1 | Bromodomain inhibitors and uses thereof | |
US2013310379A1 | Modulators of methyl modifying enzymes, compositions and uses thereof | |
US2009318436A1 | Fused heterocyclic derivatives and methods of use | |
US2009124609A1 | Fused heterocyclic derivatives and methods of use | |
WO2005113494A2 | Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer |